Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05416437 · ClinicalTrials.gov registry record · NA

Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience

A NA study of Dyspnea, sponsored by Ohio State University.

Active
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05416437 is a NA study of Dyspnea that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 80 participants, below the 302-participant average among 23 other Dyspnea trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05416437, a NA study of Dyspnea, is active but no longer recruiting, sponsored by Ohio State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The BREATHE-easy is a randomized control trial assessing the efficacy of the novel PneumoCool device to alleviate subjective shortness of breath. The PneumoCool device is a disposable, bladeless, highly portable device that uses medical-grade air that confers many advantages in a hospital setting.

Conditions Studied

Interventions

  • DEVICE PneumoCool
  • OTHER Current supportive measures that are used in the hospital for standard of care

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-06-15
Est. Completion 2025-06-30
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT05416437

The ClinicalTrials.gov registry entry for NCT05416437 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 23 other Dyspnea trials with a reported enrollment target (74% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dyspnea appearing as the primary indexed condition, and to 2 interventions - of which PneumoCool is the first listed.

NCT05416437 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05416437 about?

NCT05416437 is a clinical study titled "Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience". The BREATHE-easy is a randomized control trial assessing the efficacy of the novel PneumoCool device to alleviate subjective shortness of breath. The PneumoCool device is a disposable, bladeless, highly portable device that uses medical-grade air that confers many advantages in a hospital setting.

What is the current status of trial NCT05416437?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-06-15. Estimated completion is 2025-06-30.

What conditions does trial NCT05416437 study?

This clinical trial studies the following conditions: Dyspnea.

What interventions are being tested in trial NCT05416437?

The interventions under investigation include: PneumoCool (DEVICE), Current supportive measures that are used in the hospital for standard of care (OTHER).

Who is sponsoring clinical trial NCT05416437?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05416437 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dyspnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.